Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/1999
11/09/1999US5981258 Composition of trans-dominant variants of viral proteins for obtaining an antiviral effect
11/09/1999US5981246 Nucleic acids encoding EPH-like receptor protein tyrosine kinases
11/09/1999US5981245 Polypeptide kinase coded by a nucleic acid sequence; antibody development; for modulating kinase receptor activation and detecting receptor ligands
11/09/1999US5981220 Nucleotide sequences coding protein associated with skin differentiation; diagnostic assays for detecting bone and skin disorders; treatment of osteoporosis, bone fractures
11/09/1999US5981215 Human criptin growth factor
11/09/1999US5981205 Nuclear Dbf2- related (Ndr) kinases
11/09/1999US5981201 Methods of detection and treatment of breast cancer
11/09/1999US5981165 Exogenous activation and expression of tyrosine hydroxylase in neural cells; culturing mammalian cells of central nervous system; treatment for parkinson's disease and other nervous system disorders
11/09/1999US5980887 Methods for enhancing angiogenesis with endothelial progenitor cells
11/09/1999US5980886 Recombinant vectors for reconstitution of liver
11/09/1999US5980885 Growth factor-induced proliferation of neural precursor cells in vivo
11/04/1999WO1999055900A2 Gcp
11/04/1999WO1999055893A1 Retroviral vectors including modified envelope escort proteins
11/04/1999WO1999055892A1 Use of triplex structure dna sequences for transferring nucleotide sequences
11/04/1999WO1999055883A2 Triacylglycerol lipases
11/04/1999WO1999055876A2 Polypeptide with immunogenic properties and with a protein with modified biological functions
11/04/1999WO1999055873A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
11/04/1999WO1999055869A1 Novel polypeptide growth factors and materials and methods for making them
11/04/1999WO1999055866A1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum
11/04/1999WO1999055858A2 Human nucleic acid sequences obtained from pancreas tumor tissue
11/04/1999WO1999055855A2 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999WO1999055854A2 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999WO1999055847A2 Enzymatic nucleic acids molecules which modulate the expressions and/or replication of hepatitis c virus
11/04/1999WO1999055831A2 Adenoviral vectors for treating disease
11/04/1999WO1999055825A1 A process of making a compound by forming a polymer from a template drug
11/04/1999WO1999055735A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999WO1999055729A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES
11/04/1999WO1999055728A2 Ese genes and proteins
11/04/1999WO1999055564A1 Materials and methods for gene therapy
11/04/1999WO1999055382A1 Adenoviral vector encoding anti-apoptotic bcl-2 gene and uses thereof
11/04/1999WO1999055380A1 Nr-CAM GENE, NUCLEIC ACIDS AND NUCLEIC ACID PRODUCTS FOR THERAPEUTIC AND DIAGNOSTIC USES FOR TUMORS
11/04/1999WO1999055379A1 A process of delivering a polynucleotide to a cell via the vascular system
11/04/1999WO1999055378A1 Method of treating endotoxemia
11/04/1999WO1999055365A1 Adenoviral vectors with tandem fiber proteins
11/04/1999WO1999055364A2 Proteins that direct the secretion of virulence proteins and vaccines comprising them
11/04/1999WO1999055360A1 Implantable system with drug-eluting cells for on-demand local drug delivery
11/04/1999WO1999055359A1 Compositions and methods for extending the action of clostridial neurotoxin
11/04/1999WO1999055345A1 Combination viral-based and gene-based therapy of tumors
11/04/1999WO1999055343A1 Cnre binding factors and uses thereof
11/04/1999WO1999055315A1 Periadventitial delivery device
11/04/1999WO1999055132A2 Generation of packaging system for human recombinant adenoviral vectors
11/04/1999WO1999046381A3 Human fgf gene and gene expression products
11/04/1999WO1999046372A3 Ribozymes capable of inhibiting the expression of the ccr5 receptor
11/04/1999WO1999045112A3 Chromosome 11-linked coronary heart disease susceptibility gene chd1
11/04/1999WO1999042585A9 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
11/04/1999WO1999042477A8 Transporter protein for saccharide-coupled medicaments
11/04/1999WO1999037788A9 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/04/1999WO1999036545A3 Adenoviral vectors with modified capsid proteins
11/04/1999WO1999036536A9 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system
11/04/1999WO1999033981A3 Human signal peptide-containing proteins
11/04/1999WO1999029865A9 A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
11/04/1999WO1999019481A3 Mammalian genes involved in viral infection and tumor suppression
11/04/1999DE19820190A1 Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor Human nucleic acid sequences from pancreatic tumor
11/04/1999CA2330033A1 Method of treating endotoxemia
11/04/1999CA2328992A1 Nr-cam gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors
11/04/1999CA2328111A1 Compositions and methods for extending the action of clostridial neurotoxin
11/04/1999CA2327506A1 Combination viral-based and gene-based therapy of tumors
11/04/1999CA2326825A1 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999CA2326824A1 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999CA2326819A1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum
11/04/1999CA2326755A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999CA2326695A1 Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis c virus infection
11/04/1999CA2326601A1 Ese genes and proteins
11/04/1999CA2326375A1 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
11/04/1999CA2326114A1 Periadventitial delivery device
11/04/1999CA2323235A1 Adenoviral vectors for treating disease
11/04/1999CA2295105A1 Generation of packaging system for human recombinant adenoviral vectors
11/03/1999EP0953647A1 Method for preparing retrovirus vector for gene therapy
11/03/1999EP0953641A2 Polynucleotide molecules encoding neospora proteins
11/03/1999EP0953637A2 Acetylcholine receptor
11/03/1999EP0953636A2 Cytokine signal regulators
11/03/1999EP0953053A2 Viral particles which are masked or unmasked with respect to a cell receptor
11/03/1999EP0953051A1 Use of chemokine antagonist molecules for their antiviral activity, particularly against an hiv type retrovirus
11/03/1999EP0953042A1 Methods and reagents for regulating telomere length and telomerase activity
11/03/1999EP0952855A1 Use of hyaluronan in gene therapy
11/03/1999EP0952846A1 Prolactin as a vaccine adjuvant
11/03/1999CN1234077A Structural and functional conservation of C. Elegans clock gene clk-1
11/03/1999CN1234075A Retroviral vector
11/03/1999CN1234073A Circularly permuted erythropoietin receptor agonists
11/03/1999CN1234071A Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12)
11/02/1999US5977343 One pot deprotection by contacting protected base with anhydrous methyl amine and contacting protected 2'hydroxyl group with triethylamine*3 hydrogen fluoride; high yield with high biological activity
11/02/1999US5977337 The nucleic acid molecule may be used in the diagnosis of infection.
11/02/1999US5977320 Antibody to novel human phosphorylase kinase gamma subunit
11/02/1999US5977316 Antiidiotypic antibody which induces immune response to ganglioside gd2; anticarcinogenic/antitumor agents against melanoma, neuroblastoma, glioma, soft tissue sarcoma, and small cell carcinoma; for decreasing the risk of recurrence
11/02/1999US5977315 Murine anti-idiotype antibody 3H1
11/02/1999US5977311 53BP2 complexes
11/02/1999US5977296 Chiral peptide nucleic acid monomers and oligomers
11/02/1999US5977085 Vectors carrying coding sequence for the SpsB protein of Staphylococcus aureus
11/02/1999US5977084 Self-assembling polynucleotide delivery method
11/02/1999US5976879 Antisense oligonucleotides which combat aberrant splicing and methods of using the same
11/02/1999US5976873 Nucleic acid sequences controlling lung cell-specific gene expression
11/02/1999US5976849 Human E3 ubiquitin protein ligase
11/02/1999US5976838 Secreted proteins and polynucleotides encoding them
11/02/1999US5976837 Secreted proteins and polynucleotides encoding them
11/02/1999US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor
11/02/1999US5976815 Screening drugs/ligands of activin receptor-like kinase 7 receptor by transfecting host cell with nucleic acid encoding receptor protein, contacting cell with drug/ligand, evaluating effect on kinase activity
11/02/1999US5976814 DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
11/02/1999US5976800 Enhancement of cancer cell death
11/02/1999US5976795 Retrotransposon and methods
1 ... 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 ... 870